Arcadia Biosciences Inc. (RKDA)
NASDAQ: RKDA
· Real-Time Price · USD
3.35
-0.16 (-4.56%)
At close: Sep 26, 2025, 1:07 PM
Arcadia Biosciences Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Sep 30, 2018 | Jun 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | 1.46M | 1.2M | 914K | 1.54M | 1.31M | 1.25M | 828K | 1.6M | 1.38M | 1.51M | 993K | 1.85M | 2.95M | 3.17M | 2.08M | 2.32M | 1.38M | 803K | 414K | 245K | 231K | 154K | 329K | 216K | 162K | 107K | 144K | 188K |
| Product Revenue Growth | +21.25% | +31.29% | -40.53% | +17.69% | +4.06% | +51.57% | -48.15% | +15.81% | -8.61% | +51.96% | -46.35% | -37.17% | -7.07% | +52.33% | -10.46% | +68.53% | +71.73% | +93.96% | +68.98% | +6.06% | +50.00% | -53.19% | +52.31% | +33.33% | +51.40% | -25.69% | -23.40% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.12M | 1.74M | 2.65M | 2.24M | 2.68M | 3.19M | 3.42M | 3.44M | 3.81M | 4.39M | 4.21M | 4.83M | 4.65M | 4.35M | 6.19M | 6.31M | 6.37M | 4.07M | 4.78M | 4.29M | 3.67M | 3.72M | 3.13M | 4.48M | 3.15M | 2.81M | 3.02M | 3.01M | 2.95M | 2.62M | 2.24M | 2.42M | 2.94M | 3.05M | 3.37M | 2.69M | 2.76M | 3.44M | 2.88M | 2.82M | 2.79M | 2.64M |
| Selling, General, and Administrative Revenue Growth | +22.15% | -34.54% | +18.47% | -16.47% | -15.87% | -6.84% | -0.58% | -9.75% | -13.14% | +4.22% | -12.84% | +3.93% | +6.97% | -29.72% | -1.96% | -0.91% | +56.55% | -14.84% | +11.32% | +16.82% | -1.32% | +18.83% | -30.02% | +42.35% | +11.84% | -6.98% | +0.40% | +2.10% | +12.51% | +16.96% | -7.20% | -17.94% | -3.57% | -9.38% | +25.34% | -2.61% | -19.70% | +19.39% | +2.13% | +1.18% | +5.57% | n/a |
| Research and Development Revenue | 9K | n/a | 13K | 24K | 10K | 272K | 332K | 305K | 391K | 359K | 500K | 255K | 359K | 395K | 561K | 1.04M | 1.13M | 1.16M | 1.96M | 1.76M | 1.99M | 2.24M | 1.71M | 1.93M | 1.95M | 1.5M | 1.54M | 1.33M | 1.79M | 1.4M | 2.17M | 1.75M | 1.67M | 1.82M | 1.99M | 2.25M | 2.22M | 2.2M | 1.87M | 3.18M | 2.09M | 1.83M |
| Research and Development Revenue Growth | n/a | -100.00% | -45.83% | +140.00% | -96.32% | -18.07% | +8.85% | -21.99% | +8.91% | -28.20% | +96.08% | -28.97% | -9.11% | -29.59% | -45.95% | -8.22% | -2.42% | -40.90% | +11.29% | -11.59% | -11.19% | +31.15% | -11.39% | -0.97% | +29.57% | -2.59% | +15.82% | -25.64% | +28.51% | -35.55% | +23.84% | +4.79% | -8.45% | -8.39% | -11.75% | +1.76% | +0.64% | +17.82% | -41.21% | +52.40% | +13.86% | n/a |